-
公开(公告)号:US11013549B2
公开(公告)日:2021-05-25
申请号:US14379917
申请日:2013-03-07
发明人: Neil Barman , Ayala Hezi-Yamit , Stefan Tunev
IPC分类号: A61B18/14 , A61B5/00 , A61B18/02 , A61B18/18 , A61B18/20 , A61N7/00 , A61B18/00 , A61N1/36 , A61F7/12 , A61N7/02 , A61B18/24 , A61F7/00
摘要: Methods for treating gastrointestinal conditions, conditions associated with sympathetic and/or parasympathetic activity in the gastrointestinal organs, and conditions associated with central sympathetic and/or parasympathetic activity in a patient with therapeutic gastrointestinalneuromodulation and associated systems and methods are disclosed herein. One aspect of the present technology is directed to methods that at least partially inhibit sympathetic neural activity in nerves proximate a gastrointestinal artery of a gastrointestinal organ of a patient. Sympathetic drive in the patient can thereby be reduced in a manner that treats the patient for the gastrointestinal condition.
-
公开(公告)号:US10342592B2
公开(公告)日:2019-07-09
申请号:US14379834
申请日:2013-03-07
发明人: Stefan Tunev , Julie Trudel
IPC分类号: A61B18/00 , A61B18/04 , A61N1/05 , A61N1/36 , A61B18/02 , A61B18/14 , A61B18/18 , A61M25/00 , A61N1/32 , A61N7/00
摘要: Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to methods including selectively neuromodulating afferent or efferent renal nerves. One or more measurable physiological parameters corresponding to systemic sympathetic overactivity or hyperactivity in the patient can thereby be reduced. Selectively neuromodulating afferent renal nerves can include inhibiting sympathetic neural activity in nerves proximate a renal pelvis. This can include, for example, neuromodulating via fluid within the renal pelvis. Selectively neuromodulating efferent renal nerves can include inhibiting sympathetic neural activity in nerves proximate a portion of a renal artery or a renal branch artery proximate a renal parenchyma. This can include, for example, neuromodulating via a therapeutic element within the portion of the renal artery or the renal branch artery.
-
公开(公告)号:US20150133850A1
公开(公告)日:2015-05-14
申请号:US14379834
申请日:2013-03-07
发明人: Stefan Tunev , Julie Trudel
CPC分类号: A61B18/04 , A61B18/02 , A61B18/1492 , A61B18/1815 , A61B2018/00434 , A61B2018/046 , A61M25/0084 , A61M2025/0089 , A61M2202/048 , A61M2202/049 , A61N1/0551 , A61N1/327 , A61N1/3605 , A61N7/00 , A61N2007/003
摘要: Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to methods including selectively neuromodulating afferent or efferent renal nerves. One or more measurable physiological parameters corresponding to systemic sympathetic overactivity or hyperactivity in the patient can thereby be reduced. Selectively neuromodulating afferent renal nerves can include inhibiting sympathetic neural activity in nerves proximate a renal pelvis. This can include, for example, neuromodulating via fluid within the renal pelvis. Selectively neuromodulating efferent renal nerves can include inhibiting sympathetic neural activity in nerves proximate a portion of a renal artery or a renal branch artery proximate a renal parenchyma. This can include, for example, neuromodulating via a therapeutic element within the portion of the renal artery or the renal branch artery.
摘要翻译: 本文公开了使用治疗性肾神经调节和相关联的装置,系统和方法治疗患者的方法。 本技术的一个方面涉及包括选择性神经调节传入或传出肾神经的方法。 因此可以减少对应于患者的全身交感神经过度活动或多动症的一个或多个可测量的生理参数。 选择性神经调节传入肾神经可以包括抑制邻近肾盂的神经中的交感神经活动。 这可以包括例如通过肾盂内的流体进行神经调节。 选择性神经调节传出肾神经可以包括抑制邻近肾动脉的一部分或靠近肾实质的肾分支动脉的神经中的交感神经活动。 这可以包括例如通过肾动脉或肾分支动脉部分内的治疗元件神经调节。
-
4.
公开(公告)号:US20150119867A1
公开(公告)日:2015-04-30
申请号:US14379917
申请日:2013-03-07
发明人: Neil Barman , Ayala Hezi-Yamit , Stefan Tunev
CPC分类号: A61B18/14 , A61B5/4035 , A61B5/42 , A61B18/02 , A61B18/1492 , A61B18/18 , A61B18/1815 , A61B18/20 , A61B18/24 , A61B2018/0016 , A61B2018/00214 , A61B2018/00434 , A61B2018/00494 , A61B2018/00577 , A61B2018/00773 , A61B2018/00791 , A61B2018/00839 , A61B2018/0212 , A61B2018/1861 , A61F7/123 , A61F2007/0056 , A61F2007/126 , A61N1/36007 , A61N7/00 , A61N7/022 , A61N2007/003 , A61N2007/0043
摘要: Methods for treating gastrointestinal conditions, conditions associated with sympathetic and/or parasympathetic activity in the gastrointestinal organs, and conditions associated with central sympathetic and/or parasympathetic activity in a patient with therapeutic gastrointestinalneuromodulation and associated systems and methods are disclosed herein. One aspect of the present technology is directed to methods that at least partially inhibit sympathetic neural activity in nerves proximate a gastrointestinal artery of a gastrointestinal organ of a patient. Sympathetic drive in the patient can thereby be reduced in a manner that treats the patient for the gastrointestinal condition.
摘要翻译: 本文公开了治疗胃肠道病症,与胃肠器官中的交感神经和/或副交感神经活动相关的病症以及与患有治疗性胃肠消化瘤调节及相关系统和方法的患者中枢交感神经和/或副交感神经活动相关的病症的方法。 本技术的一个方面涉及至少部分地抑制患者胃肠器官的胃肠动脉附近的神经中的交感神经活动的方法。 从而可以以对待患者胃肠道状况的方式减少患者的交感驱动。
-
-
-